Clinical Feasibility & Validation of the Virtual Reality GlenxRose Speech-Language Therapies

Launched by UNIVERSITY OF ALBERTA · Jan 14, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring a new way to help people with speech disorders, particularly those experiencing vocal cord dysfunction, by using virtual reality (VR) technology. The goal is to make speech-language therapy more engaging and enjoyable, which may help patients stick to their treatment plans. Traditional therapy can sometimes feel tedious, but by incorporating fun, game-like elements through VR, the hope is that patients will find it easier to practice and improve their speech. The study will also look at how well this new approach works compared to standard therapy.

If you or a loved one is an adult receiving speech therapy at the Glenrose Rehabilitation Hospital in Edmonton, Canada, and you are comfortable speaking English, you might be eligible to participate. However, individuals with severe cognitive or behavioral issues, communication disorders that affect understanding, or certain previous medical conditions may not qualify. Participants will get to try out the VR therapy and provide feedback on their experience, which will help researchers understand its effectiveness and how it can be integrated into regular care for speech disorders.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults receiving speech-language therapy at the Glenrose Rehabilitation Hospital (Edmonton, AB, Canada; Alberta Health Services)
• • Presence of a speech disorder
• • Proficiency in English
• • Able to provide signed informed consent to participate in the study
• Exclusion Criteria:
• • Severe cognitive impairments and/or behavioural impairments
• • Communication disorders that impact comprehension of verbal commands and understanding of scale used in the study
• • Previous history of neurological or psychiatric disorder
• • Substance use disorders